» Articles » PMID: 18397177

Endosomal NADPH Oxidase Regulates C-Src Activation Following Hypoxia/reoxygenation Injury

Overview
Journal Biochem J
Specialty Biochemistry
Date 2008 Apr 10
PMID 18397177
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

c-Src has been shown to activate NF-kappaB (nuclear factor kappaB) following H/R (hypoxia/reoxygenation) by acting as a redox-dependent IkappaBalpha (inhibitory kappaB) tyrosine kinase. In the present study, we have investigated the redox-dependent mechanism of c-Src activation following H/R injury and found that ROS (reactive oxygen species) generated by endosomal Noxs (NADPH oxidases) are critical for this process. Endocytosis following H/R was required for the activation of endosomal Noxs, c-Src activation, and the ability of c-Src to tyrosine-phosphorylate IkappaBalpha. Quenching intra-endosomal ROS during reoxygenation inhibited c-Src activation without affecting c-Src recruitment from the plasma membrane to endosomes. However, siRNA (small interfering RNA)-mediated knockdown of Rac1 prevented c-Src recruitment into the endosomal compartment following H/R. Given that Rac1 is a known activator of Nox1 and Nox2, we investigated whether these two proteins were required for c-Src activation in Nox-deficient primary fibroblasts. Findings from these studies suggest that both Nox1 and Nox2 participate in the initial redox activation of c-Src following H/R. In summary, our results suggest that Rac1-dependent Noxs play a critical role in activating c-Src following H/R injury. This signalling pathway may be a useful therapeutic target for ischaemia/reperfusion-related diseases.

Citing Articles

Involvement of NADPH oxidases in the Na/K‑ATPase/Src/ROS oxidant amplification loop in renal fibrosis.

Zhang H, Lai F, Cheng X, Wang Y Mol Med Rep. 2023; 28(3).

PMID: 37417374 PMC: 10407618. DOI: 10.3892/mmr.2023.13048.


Role of c-Src and reactive oxygen species in cardiovascular diseases.

Hussain M, Ikram W, Ikram U Mol Genet Genomics. 2023; 298(2):315-328.

PMID: 36700976 DOI: 10.1007/s00438-023-01992-9.


NOX as a Therapeutic Target in Liver Disease.

Matuz-Mares D, Vazquez-Meza H, Vilchis-Landeros M Antioxidants (Basel). 2022; 11(10).

PMID: 36290761 PMC: 9598239. DOI: 10.3390/antiox11102038.


The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease.

Herranz-Iturbide M, Penuelas-Haro I, Espinosa-Sotelo R, Bertran E, Fabregat I Cells. 2021; 10(9).

PMID: 34571961 PMC: 8470857. DOI: 10.3390/cells10092312.


Mechanisms underlying unidirectional laminar shear stress-mediated Nrf2 activation in endothelial cells: Amplification of low shear stress signaling by primary cilia.

Ishii T, Warabi E, Mann G Redox Biol. 2021; 46:102103.

PMID: 34425388 PMC: 8379703. DOI: 10.1016/j.redox.2021.102103.


References
1.
Smart J, Oppermann H, Czernilofsky A, Purchio A, Erikson R, Bishop J . Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc Natl Acad Sci U S A. 1981; 78(10):6013-7. PMC: 348967. DOI: 10.1073/pnas.78.10.6013. View

2.
Ushio-Fukai M . Localizing NADPH oxidase-derived ROS. Sci STKE. 2006; 2006(349):re8. DOI: 10.1126/stke.3492006re8. View

3.
Thomas S, Brugge J . Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997; 13:513-609. DOI: 10.1146/annurev.cellbio.13.1.513. View

4.
Chen J, Zeng H, Tuo Q, Yu H, Meyrick B, Aschner J . NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol. 2007; 292(4):H1664-74. PMC: 2383323. DOI: 10.1152/ajpheart.01138.2006. View

5.
Choi M, Lee I, Kim G, Kim B, Han Y, Yu D . Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature. 2005; 435(7040):347-53. DOI: 10.1038/nature03587. View